Italy Neurology Devices Market Trends
Cerebrospinal Fluid Management Segment is Expected to Show Better Growth in the Forecast Years
Based on type of device, the market is segmented into cerebrospinal fluid management device, interventional neurology device, neurostimulation device and other type of devices. Cerebral spinal fluid (CSF) shunt systems are used to treat hydrocephalus, which is a common medical procedure and a life-saving treatment for many patients. These shunt systems drain excess fluid from the brain to another part of the body, where the fluid is absorbed as part of the circulatory process. The CSF imbalance can lead to elevated intracranial pressure (ICP), which can lead to a variety of complications. CSF shunts can be used to alleviate these problems in patients who suffer from hydrocephalus. The need for diagnosis and treatment of neurological disorders have made significant progress in recent years, which is expected to drive the market growth in the forecast period.Italy Neurology Devices Market Competitor Analysis
The global players in the Italy neurology devices market are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, MicroPort Scientific, Nihon Kohden Corporation, Penumbra Inc., Smith & Nephew plc, and Stryker Corporation.Additional benefits of purchasing the report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- MicroPort Scientific
- Nihon Kohden Corporation
- Penumbra Inc.
- Smith & Nephew plc
- Stryker Corporation
Methodology
LOADING...